Explanatory Therapy in Hypochondriasis
J Clin Psychiatry 2000;61(4):317-322
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: The aim of the study was to evaluate
the effectiveness of individual explanatory therapy in
Method: Twenty patients with DSM-IV
hypochondriasis were randomly assigned to 2 groups. One received
explanatory therapy and was assessed again after a 6-month
follow-up. The other was first assigned to a waiting list and
subsequently treated with explanatory therapy. All patients
received usual medical care from their physicians. Assessments
involved both observer and self-rated instruments.
Results: In both groups, explanatory therapy was
significantly associated with a reduction of hypochondriacal
fears and beliefs, improvement in affective disturbances and
anxiety sensitivity, and a decrease in health care utilization.
Therapeutic gains were maintained at follow-up. Substantial
residual symptomatology, however, remained.
Conclusion: The results suggest that
hypochondriasis is a treatable condition and that explanatory
therapy is a viable therapeutic tool. Further research should
disclose the actual components of the mechanism of change in